| Literature DB >> 30222419 |
Yun Jung Choi1, HyeJung Jeon1, Sinae Kim1, YunJeong In1, Soo Yeon Park1, MiYeon Park1, Sumi Park1, YooMi Lee1, Sulhwa Kim1, Kyu-Pyo Kim1,2, Ha Yeong Koo1, Tae Won Kim1,2.
Abstract
Delays in trial opening should be considered critical for the sake of not only the sponsor but the patients, as they may result in inequities of care. The Asan Medical Center, in Seoul, Korea, implemented a trial activation initiative in July 2012, in an aim to expedite the trial initiation timeline. Time intervals between trial initiation steps and the rate of institutional review board (IRB) and clinical trial agreement (CTA) parallel submission were assessed. A higher rate of parallel IRB and CTA submissions was observed after initiative implementation (25.5% vs 52.3%; P < .001). Initiative applications were shown to significantly accelerate the median trial opening time, from 114 to 81 days ( P < .001). Strategic processing of parallel submissions greatly shortened the median time required for trial initiation from 117 to 61 days compared with sequential submissions ( P < .001). A trial activation initiative including parallel IRB and CTA submissions is an effective tool for accelerating trial commencements.Entities:
Keywords: clinical trial agreement; contract; cycle time; parallel submissions; study start up
Year: 2015 PMID: 30222419 DOI: 10.1177/2168479014554399
Source DB: PubMed Journal: Ther Innov Regul Sci ISSN: 2168-4790 Impact factor: 1.778